Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets

被引:59
作者
Plutzky, J
Viberti, G
Haffner, S
机构
[1] Brigham & Womens Hosp, Dept Cardiovasc Med, Boston, MA 02115 USA
[2] Kings Coll London, GKT Sch Med, Unit Metab Med, London WC2R 2LS, England
[3] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA
关键词
cardiovascular risk; insulin resistance; microalbuminuria; thiazolidinediones; inflammation;
D O I
10.1016/S1056-8727(02)00202-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ongoing heavy burden of cardiovascular disease associated with diabetes mellitus highlights the failure of current treatment strategies to address effectively the cardiovascular risk profile in such patients. Insulin resistance is not only an underlying feature in most cases of type 2 diabetes, but is also associated, through the Insulin Resistance Syndrome, with cardiovascular risk factors that promote atherothrombosis through diverse mechanisms. Growing evidence suggests that treatment with anti-diabetic agents that improve insulin sensitivity, such as the thiazolidinediones, improve multiple components of the Insulin Resistance Syndrome, have beneficial effects on various atherothrombotic mechanisms, and reduce atherosclerosis in animal models and perhaps humans as well. Given data implicating chronic inflammation as a central feature of atherosclerosis, the anti-inflammatory activity of the thiazolidinediones may contribute to their potential anti-atherosclerotic effects. An improved understanding of the mechanisms linking diabetes, atherosclerosis, and cardiovascular disease is needed in order to understand how these and other current and emerging therapies might reduce diabetes-associated cardiovascular disease. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:401 / 415
页数:15
相关论文
共 160 条
  • [1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [2] Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide
    Aljada, A
    Saadeh, R
    Assian, E
    Ghanim, H
    Dandona, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2572 - 2575
  • [3] Tumor necrosis factor-α inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells
    Aljada, A
    Ghanim, H
    Assian, E
    Dandona, P
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (04): : 487 - 491
  • [4] Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes:: Evidence of an antiinflammatory action?
    Aljada, A
    Garg, R
    Ghanim, H
    Mohanty, P
    Hamouda, W
    Assian, E
    Dandona, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) : 3250 - 3256
  • [5] Microalbuminuria in patients with NIDDM: An overview
    Alzaid, AA
    [J]. DIABETES CARE, 1996, 19 (01) : 79 - 89
  • [6] Insulin down-regulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells
    Aubert, J
    Safonova, I
    Negrel, R
    Ailhaud, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) : 77 - 82
  • [7] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [8] Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease
    Bakogianni, MC
    Kalofoutis, CA
    Skenderi, KI
    Kalofoutis, AT
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (05) : 265 - 269
  • [9] Bakris G, 1999, DIABETOLOGIA, V42, pA230
  • [10] Bakris G L, 2001, J Clin Hypertens (Greenwich), V3, P99